Analystreport

ZEALAND PHARMA/S (NASDAQ: ZEAL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $42.00 price target on the stock.

Zealand Pharma A/S - American Depositary Shares  (ZEAL) 
Last zealand pharma a/s - american depositary shares earnings: 11/15 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: zealandpharma.com